Explore

Companies

Drugs

/

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Oncology/Gastric Carcinoma

Gastric Carcinoma

7

Pipeline Programs↗

7

Active Trials↗

9

Companies Involved↗

Gastric Carcinoma is an early-stage landscape with 7 programs across 9 companies. 1 program is in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

37/100

Pipeline Velocity

22/100

Mech. Concentration

25/100

Completion Rate

87/100

Attrition Rate

7/100

Pipeline

Programs by Phase

Preclinical2

Ramucirumab

Eli Lilly

Nivolumab

Bristol-Myers Squibb

Phase 1

No programs

Phase 24

Trastuzumab

Organon and Co

Ivonescimab

Summit Therapeutics

5-Fluorouracil

Merck & Co.

Leucovorin

Glaxo Dba Glaxosmithkline

Phase 31

Oxaliplatin

Teva

Approved

No programs

Analysis

Modality Breakdown

67%

Monoclonal antibody

4 of 6 classified programs — the dominant modality here.

Monoclonal antibody leads; the ring shows all 6 classified programs, each share of the total. Modality classified for 86% of 7 pipeline programs.

Analysis

Trial Status

27

clinical trials

Completed13 · 48%

Unknown status5 · 19%

Recruiting4 · 15%

Terminated2 · 7%

Active, not recruiting2 · 7%

Not yet recruiting1 · 4%

Clinical Trials

Trial Activity

27 trials

A Single-Arm, Phase II Study of Ivonescimab in Combination With FOLFOX in Advanced HER2 Negative Gastroesophageal Adenocarcinomas

Recruiting·MMassachusetts General Hospital·Phase 2·NCT07070466·40 enrolled

A Randomized, Controlled, Open-Label, Multicenter Clinical Trial Comparing Anti-HER2 Therapy Combined With Chemotherapy to Chemotherapy Alone as Adjuvant Therapy Following Surgery for Stage IB-II Gastric Cancer With High HER2 Expression

Recruiting·XXijing Hospital·Phase 2·NCT07788196·120 enrolled

Phase II Randomized Controlled Trial Evaluating the Necessity of Surgery in Patients With Advanced Metastatic Gastric Cancer Achieving Radiological Response After Conversion Therapy

Recruiting·FFudan University·Phase 2·NCT07757165·126 enrolled

Efficacy and Safety Assessment of Single-port Robotic Radical Gastrectomy for Gastric Cancer: a Phase 2a Trial Based on the IDEAL Framework

Recruiting·DDaping Hospital and the Research Institute of Surgery of the Third Military Medical University·Preclinical·NCT07237126·20 enrolled

Pilot Study of Dual Checkpoint Inhibition Followed by Immuno-Chemoradiation in Patients With Resectable Gastric Adenocarcinoma (Concept ID 2016-NIV-0551)

Active, not recruiting·MM.D. Anderson Cancer Center·Phase 2·NCT03776487·32 enrolled

Telehealth Intervention for Self-Management of Dietary Quality of Life After Gastric Cancer Surgery

Active, not recruiting·CCity of Hope Medical Center·Preclinical·NCT05203627·53 enrolled

A Sequential Trial of Low-Dose Radiotherapy Followed by Concurrent Immunotherapy, Systemic Chemotherapy, and Intraperitoneal Perfusion in Gastric Cancer With Peritoneal Carcinomatosis

Not yet recruiting·ZZhejiang Cancer Hospital·Phase 2·NCT07784413·40 enrolled

A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy

Completed·—·Phase 3·NCT01248403·300 enrolled

PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA

Completed·FFederation Francophone de Cancerologie Digestive·Phase 3·NCT03006432·507 enrolled

A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients

Completed· Novartis logo

Novartis·Phase 2·NCT01576380·11 enrolled

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

Completed· Eli Lilly logo

Eli Lilly·Phase 2·NCT00190801·50 enrolled

Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

Completed·SStanford University·Phase 2·NCT00780494·35 enrolled

Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma

Completed·—·Phase 2·NCT01711242·208 enrolled

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma

Completed· Eli Lilly logo

Eli Lilly·Phase 2·NCT00192088·43 enrolled

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 2·NCT04065139·66 enrolled

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)